PP_1170x120_10-25-21

hepatitis B

FDA approves generic equivalent to Viread

FDA approves generic equivalent to Viread

EAST WINDSOR, N.J. — The FDA has granted Aurobindo Pharma Limited final approval for its Abbreviated New Drug Application for Tenofovir Disoproxil Fumarate Tablets, an AB-rated generic equivalent to Viread. The generic tablets are indicated for the treatment of HIV-1 infection and chronic hepatitis B. Citing data from IMS for the twelve month period ending December 2017, Aurobindo says the

Aurobindo cleared to market Baraclude generic

Aurobindo cleared to market Baraclude generic

DAYTON, N.J. — Aurobindo Pharma Ltd. has gained approval from the Food and Drug Administration for entecavir tablets 0.5 mg and 1 mg, a medication for hepatitis B. Aurobindo, which announced the product this week, said its entecavir tablets are a generic version of Baraclude tablets (0.5 mg and 1 mg) from Bristol-Myers Squibb. Entecavir tablets

Adheris Health